# Lorbrena

NDC: 0069-0231
Generic name: lorlatinib
Labeler / Manufacturer: Pfizer Laboratories Div Pfizer Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20181119

FDA application: NDA210868

## Active ingredients

- LORLATINIB: 100 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0069-0231"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0069-0231
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2b34d62d-e02a-4af3-bc0d-1571dd4ee76d